Barclays raises price targets for Hawkins and Labcorp, keeps Equal-Weight
Barclays kept Equal-Weight ratings on Hawkins and Labcorp and raised price targets to $157 and $380, according to TradingView on October 29, 2026.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Barclays kept its Equal-Weight rating on Hawkins and lifted its price target from $141 to $157, an increase of 11.3%. The new target implies upside of 1.9% from the October 28 close of $154.06.
Barclays also kept Equal-Weight on Labcorp Holdings and raised its target from $330 to $380, a 15.2% increase. That target implies a 5.5% gain from the October 28 close of $360.25. The figures are reported by TradingView, with reference data from Benzinga.
why it matters
Price target increases with unchanged ratings usually reflect an analyst's updated view of a company's business and rarely move the shares much on their own. For investors, the signal is mainly informational, showing how the bank views each company's outlook.
tags
instruments
sources
- Barclays maintains Hawkins at Equal-Weight, raises price target to $157 from $141 — TradingView, 29 October 2026 at 15:08 UTC
- Barclays maintains Labcorp Holdings at Equal-Weight, raises price target to $380 from $330 — TradingView, 29 October 2026 at 15:12 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗